CA1190931A - Thienamycin intermediates - Google Patents

Thienamycin intermediates

Info

Publication number
CA1190931A
CA1190931A CA000418742A CA418742A CA1190931A CA 1190931 A CA1190931 A CA 1190931A CA 000418742 A CA000418742 A CA 000418742A CA 418742 A CA418742 A CA 418742A CA 1190931 A CA1190931 A CA 1190931A
Authority
CA
Canada
Prior art keywords
general formula
oxo
group
compound
dioxolan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000418742A
Other languages
English (en)
French (fr)
Inventor
Karoly Lempert
Gabor Doleschall
Jozsef Fetter
Gyula Simig
Jozsef Nuitrai
Gyula Hornyak
Kalman Harsanyi
Karoly Zauer
Gyorgy Fekete
Laszlo Szporny
Gyorgy Hajos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Application granted granted Critical
Publication of CA1190931A publication Critical patent/CA1190931A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/18—Oxygen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CA000418742A 1981-12-30 1982-12-30 Thienamycin intermediates Expired CA1190931A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU4015/81 1981-12-30
HU814015A HU185491B (en) 1981-12-30 1981-12-30 Process for producing new azabicyclo-bracket-3.2.0-bracket closedheptane derivatives

Publications (1)

Publication Number Publication Date
CA1190931A true CA1190931A (en) 1985-07-23

Family

ID=10966521

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000418742A Expired CA1190931A (en) 1981-12-30 1982-12-30 Thienamycin intermediates

Country Status (17)

Country Link
JP (1) JPS58118587A (de)
AT (1) AT376982B (de)
BE (1) BE895492A (de)
CA (1) CA1190931A (de)
DE (1) DE3248676A1 (de)
ES (1) ES518723A0 (de)
FI (1) FI824520L (de)
FR (1) FR2519001B1 (de)
GB (1) GB2114124A (de)
GR (1) GR77070B (de)
HU (1) HU185491B (de)
IT (1) IT1210970B (de)
LU (1) LU84569A1 (de)
NL (1) NL8205067A (de)
PL (1) PL239888A1 (de)
SE (1) SE8207478L (de)
ZA (1) ZA829596B (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5625110A (en) * 1978-12-18 1981-03-10 Bristol Myers Co Antibacterial
IE52147B1 (en) * 1980-03-27 1987-07-08 Merck & Co Inc 4-(3-carboxy-2-oxopropyl)-azetidin-2-ones and process for their preparation
JPS57176982A (en) * 1981-04-24 1982-10-30 Shionogi & Co Ltd Dioxolanylazetidinone compound, its preparation and use

Also Published As

Publication number Publication date
DE3248676A1 (de) 1983-07-07
GB2114124A (en) 1983-08-17
ES8501747A1 (es) 1984-12-16
FI824520A7 (fi) 1983-07-01
FI824520L (fi) 1983-07-01
NL8205067A (nl) 1983-07-18
PL239888A1 (en) 1984-01-02
FR2519001B1 (fr) 1985-10-25
IT1210970B (it) 1989-09-29
FR2519001A1 (fr) 1983-07-01
HU185491B (en) 1985-02-28
SE8207478L (sv) 1983-07-01
LU84569A1 (fr) 1984-10-22
GR77070B (de) 1984-09-05
FI824520A0 (fi) 1982-12-30
ATA450882A (de) 1984-06-15
JPS58118587A (ja) 1983-07-14
BE895492A (fr) 1983-06-28
SE8207478D0 (sv) 1982-12-29
ES518723A0 (es) 1984-12-16
IT8225063A0 (it) 1982-12-30
ZA829596B (en) 1983-10-26
AT376982B (de) 1985-01-25

Similar Documents

Publication Publication Date Title
ES2208812T3 (es) Derivados de azetidina y de pirrolidina.
AU8959998A (en) D-proline derivatives
KR100523184B1 (ko) 아제티딘 및 피롤리딘의 유도체
CA1190931A (en) Thienamycin intermediates
CS219944B2 (en) Method of making the racemic and optically unite derivatives of the 1-phenyl-2-cyclohexen-1-alkylamine
FR2521145A1 (fr) Phosphines chirales, procedes pour leur preparation, produits intermediaires de leur preparation, complexes de rhodium de ces phosphines et utilisation de ces derniers dans des hydrogenations asymetriques
CA1189865A (en) Heterocyclic acetic acid derivatives and a process for the preparation thereof
CA1199644A (en) Process for the preparation of heterocyclic acetic acid derivatives
JPS6366162A (ja) Ｎ−（２−アミノ−３−アルコキシ（またはアラルキルオキシ）ベンゾイル）−ｌ−プロリナ−ルアセタ−ルおよびその製造方法
FR2559765A1 (fr) Nouveaux derives de la phenyl-3 propene-2 amine, leur preparation et les medicaments qui les contiennent
CA1192202A (en) Thienamycin analogues
CA1189864A (en) Heterocyclic carboxylic acids and a process for the preparation thereof
EP1076646B1 (de) Verfahren zur stereochemisch kontrollierten herstellung isomerenreiner hochsubstituierter azacyclischer verbindungen
CA1191854A (en) Thienamycin derivatives
AU637719B2 (en) Process for preparing 1-((2s)-3-mercapto-methyl-1-oxopropyl)-l-proline
Fitremann et al. New C2 symmetric bis-aziridines efficient synthesis of (2S, 5S)-1, 6-Di (p-toluenesulfonyloxy)-2, 5-hexanediol, and (2S, 3E, 5S)-1, 6-Di (p-toluenesulfonyloxy)-2, 5-hexenediol
Kobayashi et al. Synthesis and chiral recognition ability of O-phenyl ethylphosphonothioic acid with a conformationally flexible phenoxy group for CH/π interaction
CA1189866A (en) Heterocyclic acetic acid derivatives and a process for the preparation thereof
CA1215715A (en) Heterocyclic acetic acid esters
JPH03236371A (ja) （３ｓ）―２―アゼチジノン誘導体およびその製造方法
US5089518A (en) 3- or 4-substituted oxotremorine derivatives and a method of treating cholinergic dysfunction therewith
JP3159518B2 (ja) アミノ置換スピロ化合物の製法
LEADBETTER THE SYNTHESIS OF MACROCYCLIC SPERMIDINE ALKALOIDS;(+,-)-CANNABISATIVINE,(+,-)-ANHYDROCANNABISATIVINE, AND STUDIES DIRECTED TOWARD THE SYNTHESIS OF PALUSTRINE
EP0434743A4 (en) Methods for preparing captopril and its analogues
JPS59196878A (ja) 塩酸ジルチアゼムの新規製造法

Legal Events

Date Code Title Description
MKEC Expiry (correction)
MKEX Expiry